Literature DB >> 22440612

Autophagy links inflammasomes to atherosclerotic progression.

Babak Razani1, Chu Feng, Trey Coleman, Roy Emanuel, Haitao Wen, Seungmin Hwang, Jenny P Ting, Herbert W Virgin, Michael B Kastan, Clay F Semenkovich.   

Abstract

We investigated the role of autophagy in atherosclerosis. During plaque formation in mice, autophagic markers colocalized predominantly with macrophages (mφ). Atherosclerotic aortas had elevated levels of p62, suggesting that dysfunctional autophagy is characteristic of plaques. To determine whether autophagy directly influences atherogenesis, we characterized Beclin-1 heterozygous-null and mφ-specific ATG5-null (ATG5-mφKO) mice, commonly used models of autophagy haploinsufficiency and deficiency, respectively. Haploinsufficent Beclin-1 mice had no atherosclerotic phenotype, but ATG5-mφKO mice had increased plaques, suggesting an essential role for basal levels of autophagy in atheroprotection. Defective autophagy is associated with proatherogenic inflammasome activation. Classic inflammasome markers were robustly induced in ATG5-null mφ, especially when coincubated with cholesterol crystals. Moreover, cholesterol crystals appear to be increased in ATG5-mφKO plaques, suggesting a potentially vicious cycle of crystal formation and inflammasome activation in autophagy-deficient plaques. These results show that autophagy becomes dysfunctional in atherosclerosis and its deficiency promotes atherosclerosis in part through inflammasome hyperactivation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440612      PMCID: PMC3322320          DOI: 10.1016/j.cmet.2012.02.011

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  64 in total

Review 1.  Autophagy as a regulated pathway of cellular degradation.

Authors:  D J Klionsky; S D Emr
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

2.  Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β.

Authors:  Nicolas Dupont; Shanya Jiang; Manohar Pilli; Wojciech Ornatowski; Dhruva Bhattacharya; Vojo Deretic
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

3.  Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux.

Authors:  P G Yancey; W G Jerome
Journal:  J Lipid Res       Date:  2001-03       Impact factor: 5.922

4.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

5.  Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice.

Authors:  ZhongMao Guo; Felicia Mitchell-Raymundo; Hong Yang; Yuji Ikeno; James Nelson; Vivian Diaz; Arlan Richardson; Robert Reddick
Journal:  Mech Ageing Dev       Date:  2002-04-30       Impact factor: 5.432

6.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

Authors:  Sanjeev Mariathasan; Kim Newton; Denise M Monack; Domagoj Vucic; Dorothy M French; Wyne P Lee; Meron Roose-Girma; Sharon Erickson; Vishva M Dixit
Journal:  Nature       Date:  2004-06-09       Impact factor: 49.962

8.  Cholesterol crystal formation and growth in model bile solutions.

Authors:  M J Whiting; J M Watts
Journal:  J Lipid Res       Date:  1983-07       Impact factor: 5.922

9.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

10.  Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.

Authors:  Claudia Castro; Josep M Campistol; David Sancho; Francisco Sánchez-Madrid; Elena Casals; Vicente Andrés
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

View more
  216 in total

Review 1.  Autophagy and autophagy-related proteins in the immune system.

Authors:  Shusaku T Shibutani; Tatsuya Saitoh; Heike Nowag; Christian Münz; Tamotsu Yoshimori
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

2.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

Review 3.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

Review 4.  The cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other?

Authors:  Dalia H A Abdelaziz; Hany Khalil; Estelle Cormet-Boyaka; Amal O Amer
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 5.  MicroRNA control of high-density lipoprotein metabolism and function.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

Review 6.  Autophagy as a crosstalk mediator of metabolic organs in regulation of energy metabolism.

Authors:  Kook Hwan Kim; Myung-Shik Lee
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 7.  Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis.

Authors:  C Barbati; M Vomero; T Colasanti; F Ceccarelli; M Marcosano; F Miranda; L Novelli; A Pecani; Carlo Perricone; F R Spinelli; S Truglia; F Conti; G Valesini; C Alessandri
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 8.  Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?

Authors:  Paul M Ridker
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

9.  Physiological difference in autophagic flux in macrophages from 2 mouse strains regulates cholesterol ester metabolism.

Authors:  Peggy Robinet; Brian Ritchey; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-14       Impact factor: 8.311

10.  PPARγ Deficiency Suppresses the Release of IL-1β and IL-1α in Macrophages via a Type 1 IFN-Dependent Mechanism.

Authors:  Kassandra J Weber; Madeline Sauer; Li He; Eric Tycksen; Gowri Kalugotla; Babak Razani; Joel D Schilling
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.